GlassScriptPhysician profile
Bryan Hiscox
NPI 1093072571
$38,683.95
in general payments reported to CMS, 2019-2025
37 companies · $7,342 in 2025
The $7,342 reported for 2025 was more than what 91% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $847 · 2021: $3,583 · 2022: $5,473 · 2023: $8,312 · 2024: $13K · 2025: $7,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Consulting Fee: $11K · Travel and Lodging: $1,231 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,297.30 |
| Consulting Fee | $10,952.50 |
| Travel and Lodging | $1,231.48 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,423.36 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $6,198.39 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $4,005.34 | 2020-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $3,635.41 | 2023-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $2,157.10 | 2021-2025 | |
| Genzyme Corporation | $1,806.90 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,725.12 | 2020-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $1,562.00 | 2020-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $1,531.30 | 2021-2025 | Opzelura |
| Amgen INC. | $1,203.17 | 2020-2025 | Otezla, Otezla |
| Journey Medical Corporation | $1,185.86 | 2019-2025 | |
| Ucb, INC. | $986.92 | 2020-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $951.66 | 2020-2025 | Aklief, Oracea, Nemluvio |
| Sun Pharmaceutical Industries INC. | $903.24 | 2020-2025 | Ilumya |
| Celgene Corporation | $841.44 | 2024 | Sotyktu |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $795.43 | 2019-2025 | Adbry, Anzupgo |
| Pfizer INC. | $697.39 | 2021-2025 | |
| Dermavant Sciences, INC. | $407.30 | 2022-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $365.77 | 2020-2025 | Cabtreo, Jublia, Targretin |
| Vyne Pharmaceuticals INC. | $322.46 | 2020-2021 | |
| Organon LLC | $116.61 | 2023-2025 | Vtama, Hadlima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.39 | 2022-2024 | Spevigo, Cyltezo |
| Epi Health, LLC | $101.17 | 2021-2022 | |
| Almirall LLC | $91.98 | 2020-2022 | |
| Biofrontera INC. | $86.19 | 2021-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Hill Dermaceuticals, INC. | $85.77 | 2020 | |
| Eli Lilly and Company | $78.79 | 2025 | Ebglyss |
| Springworks Therapeutics, INC. | $77.42 | 2025 | Gomekli |
| Verrica Pharmaceuticals INC. | $38.94 | 2023-2025 | Ycanth |
| Convatec INC. | $32.45 | 2025 | |
| Dermira, INC. | $26.32 | 2020 | |
| Mayne Pharma Commercial LLC | $24.70 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $24.37 | 2021 | |
| Genentech USA, INC. | $23.74 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.04 | 2021 | |
| Fidia Pharma USA INC. | $20.13 | 2025 | |
| Botanix Sb INC | $17.38 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Hiscox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.